Infographics - Atopic Dermatitis Market

Atopic dermatitis (AD), or eczema, is a chronic condition that causes dry, itchy, and inflamed skin. It is the most common chronic skin disease and is genetically transmitted. It can be irritating but it is not contagious. Atopic dermatitis is chronic condition and tends to flare sometimes. It’s common in young children but can occur at any age. There is no cure for atopic dermatitis, and many people have troubling controlling it.

Market Dynamics:

Increasing prevalence of atopic dermatitis across the world, rise in awareness among people about atopic dermatitis, growing government expenditure regarding atopic dermatitis, increase in focus on the development of novel therapeutics, and outbreak of COVID-19 (global pandemic) are major factors expected to drive growth of the global atopic dermatitis market.

For instance, in February 2022, Evelo Biosciences reported that the first patient has been dosed in EDP1815-207, its Phase 2 randomized clinical trial of EDP1815 for the treatment of patients with mild, moderate, and severe atopic dermatitis.

Moreover, in October 2022, LEO Pharma A/S, launched AD Days Around the World, a global disease awareness campaign that highlights the experiences of people living with atopic dermatitis (AD); the most common form of atopic dermatitis.

Key features of the study:

This report provides in-depth analysis of the global atopic dermatitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global atopic dermatitis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Nestle, LEO Pharma AS, Encore Dermatology Inc., GlaxoSmithKline PLC, Allergan PLC, AbbVie Inc., Regeneron Pharmaceuticals Inc., and Bausch Health Companies Inc., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global atopic dermatitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atopic dermatitis market.

Detailed Segmentation:

Global Atopic Dermatitis Market, By Drug Class:
- Corticosteroids
- Emollients/Moisturizers
- IL-4 & PDE4 Inhibitors
- Calcineurin Inhibitors Antibiotics
- Other Drug Classes
Global Atopic Dermatitis Market, By Type of Administration:
- Topical
- Oral
- Injectable
Global Atopic Dermatitis Market, By Prescription Type:
- Over-the-counter (OTC)
- Prescription
Global Atopic Dermatitis Market, By Geography:
- North America
- Europe
- Asia Pacific
- Middle East
- Africa
- Latin America
Company Profiles:
- Pfizer Inc.
- Novartis AG
- Nestle
- LEO Pharma AS
- Encore Dermatology Inc.
- GlaxoSmithKline PLC
- Allergan PLC
- AbbVie Inc.
- Regeneron Pharmaceuticals Inc.
- Bausch Health Companies Inc.

Table of Contents:

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Class
  - Market Snapshot, By Type of Administration
  - Market Snapshot, By Prescription Type
  - Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Rise in prevalence of atopic dermatitis worldwide
  - Adverse effects of certain therapeutic drugs
  - Increase in demand for safe/effective treatments
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Atopic Dermatitis Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Global Atopic Dermatitis Market, By Drug Class, 2017-2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- Corticosteroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Emollients/Moisturizers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- IL-4 & PDE4 Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Calcineurin Inhibitors Antibiotics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Other Drug Classes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Global Atopic Dermatitis Market, By Type of Administration, 2017-2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- Topical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Global Atopic Dermatitis Market, By Prescription Type, 2017-2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- Over-the-counter (OTC)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Prescription
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Global Atopic Dermatitis Market, By Geography, 2017-2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2022 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2017-2028,(US$ Mn)
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2017-2028,(US$ Mn)
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2017-2028,(US$ Mn)
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2017-2028,(US$ Mn)
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2017-2028,(US$ Mn)
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Administration, 2017-2028,(US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Prescription Type, 2017-2028,(US$ Mn)
Competitive Landscape
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Nestle
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- LEO Pharma AS
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Encore Dermatology Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GlaxoSmithKline PLC
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Allergan PLC
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Regeneron Pharmaceuticals Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bausch Health Companies Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 24 market data tables and 28 figures on "Global Atopic Dermatitis Market” - Global forecast to 2028

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

ATOPIC DERMATITIS MARKET ANALYSIS

Atopic Dermatitis Market

Need a Custom Report?

EXISTING CLIENTELE